Global and China Latisse (Bimatoprost) ( CAS 155206-00-1) Market Insights, Forecast to 2027
Table of Contents1 Study Coverage
1.1 Latisse (Bimatoprost) ( CAS 155206-00-1) Product Introduction
1.2 Market by Type
1.2.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size Growth Rate by Type
1.2.2 Medicine Grade
1.2.3 Cosmetic Grade
1.3 Market by Application
1.3.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size Growth Rate by Application
1.3.2 Medicine
1.3.3 Cosmetic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, Estimates and Forecasts
2.1.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue 2016-2027
2.1.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales 2016-2027
2.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Latisse (Bimatoprost) ( CAS 155206-00-1) Historical Market Size by Region (2016-2021)
2.3.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Latisse (Bimatoprost) ( CAS 155206-00-1) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Region (2022-2027)
2.4.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Region (2022-2027)
3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Competitor Landscape by Players
3.1 Global Top Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturers by Sales
3.1.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Manufacturer (2016-2021)
3.1.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturers by Revenue
3.2.1 Key Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Manufacturers (2016-2021)
3.2.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue in 2020
3.2.6 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price by Manufacturers
3.4 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturing Base Distribution, Product Types
3.4.1 Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Latisse (Bimatoprost) ( CAS 155206-00-1) Product Type
3.4.3 Date of International Manufacturers Enter into Latisse (Bimatoprost) ( CAS 155206-00-1) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size by Type (2016-2021)
4.1.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Type (2016-2021)
4.1.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Type (2016-2021)
4.1.3 Latisse (Bimatoprost) ( CAS 155206-00-1) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size Forecast by Type (2022-2027)
4.2.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Type (2022-2027)
4.2.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Type (2022-2027)
4.2.3 Latisse (Bimatoprost) ( CAS 155206-00-1) Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size by Application (2016-2021)
5.1.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Application (2016-2021)
5.1.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Application (2016-2021)
5.1.3 Latisse (Bimatoprost) ( CAS 155206-00-1) Price by Application (2016-2021)
5.2 Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size Forecast by Application (2022-2027)
5.2.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Application (2022-2027)
5.2.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Application (2022-2027)
5.2.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size YoY Growth 2016-2027
6.1.1 China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales YoY Growth 2016-2027
6.1.2 China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue YoY Growth 2016-2027
6.1.3 China Latisse (Bimatoprost) ( CAS 155206-00-1) Market Share in Global Market 2016-2027
6.2 China Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size by Players (International and Local Players)
6.2.1 China Top Latisse (Bimatoprost) ( CAS 155206-00-1) Players by Sales (2016-2021)
6.2.2 China Top Latisse (Bimatoprost) ( CAS 155206-00-1) Players by Revenue (2016-2021)
6.3 China Latisse (Bimatoprost) ( CAS 155206-00-1) Historic Market Review by Type (2016-2021)
6.3.1 China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2016-2021)
6.3.2 China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Type (2016-2021)
6.3.3 China Latisse (Bimatoprost) ( CAS 155206-00-1) Price by Type (2016-2021)
6.4 China Latisse (Bimatoprost) ( CAS 155206-00-1) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Type (2022-2027)
6.4.2 China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Type (2022-2027)
6.4.3 China Latisse (Bimatoprost) ( CAS 155206-00-1) Price Forecast by Type (2022-2027)
6.5 China Latisse (Bimatoprost) ( CAS 155206-00-1) Historic Market Review by Application (2016-2021)
6.5.1 China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2016-2021)
6.5.2 China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Application (2016-2021)
6.5.3 China Latisse (Bimatoprost) ( CAS 155206-00-1) Price by Application (2016-2021)
6.6 China Latisse (Bimatoprost) ( CAS 155206-00-1) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Application (2022-2027)
6.6.2 China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Application (2022-2027)
6.6.3 China Latisse (Bimatoprost) ( CAS 155206-00-1) Price Forecast by Application (2022-2027)
7 North America
7.1 North America Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size YoY Growth 2016-2027
7.2 North America Latisse (Bimatoprost) ( CAS 155206-00-1) Market Facts & Figures by Country
7.2.1 North America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2016-2021)
7.2.2 North America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Latisse (Bimatoprost) ( CAS 155206-00-1) Market Facts & Figures by Region
8.2.1 Asia Pacific Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Region (2016-2021)
8.2.2 Asia Pacific Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size YoY Growth 2016-2027
9.2 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Market Facts & Figures by Country
9.2.1 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2016-2021)
9.2.2 Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size YoY Growth 2016-2027
10.2 Latin America Latisse (Bimatoprost) ( CAS 155206-00-1) Market Facts & Figures by Country
10.2.1 Latin America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2016-2021)
10.2.2 Latin America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Market Facts & Figures by Country
11.2.1 Middle East and Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Allergan plc (AbbVie Inc.)
12.1.1 Allergan plc (AbbVie Inc.) Corporation Information
12.1.2 Allergan plc (AbbVie Inc.) Description and Business Overview
12.1.3 Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Products Offered
12.1.5 Allergan plc (AbbVie Inc.) Recent Development
12.2 Sandoz(Novartis)
12.2.1 Sandoz(Novartis) Corporation Information
12.2.2 Sandoz(Novartis) Description and Business Overview
12.2.3 Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Products Offered
12.2.5 Sandoz(Novartis) Recent Development
12.3 Hi-Tech Pharmacal
12.3.1 Hi-Tech Pharmacal Corporation Information
12.3.2 Hi-Tech Pharmacal Description and Business Overview
12.3.3 Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Products Offered
12.3.5 Hi-Tech Pharmacal Recent Development
12.4 Apotex Inc.
12.4.1 Apotex Inc. Corporation Information
12.4.2 Apotex Inc. Description and Business Overview
12.4.3 Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Products Offered
12.4.5 Apotex Inc. Recent Development
12.11 Allergan plc (AbbVie Inc.)
12.11.1 Allergan plc (AbbVie Inc.) Corporation Information
12.11.2 Allergan plc (AbbVie Inc.) Description and Business Overview
12.11.3 Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Products Offered
12.11.5 Allergan plc (AbbVie Inc.) Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Latisse (Bimatoprost) ( CAS 155206-00-1) Industry Trends
13.2 Latisse (Bimatoprost) ( CAS 155206-00-1) Market Drivers
13.3 Latisse (Bimatoprost) ( CAS 155206-00-1) Market Challenges
13.4 Latisse (Bimatoprost) ( CAS 155206-00-1) Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Latisse (Bimatoprost) ( CAS 155206-00-1) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Medicine Grade
Table 3. Major Manufacturers of Cosmetic Grade
Table 4. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size Growth Rate by Application (2021-2027) & (Kiloton)
Table 5. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size by Region (Kiloton) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Regions (2016-2021) & (Kiloton)
Table 7. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Regions (2016-2021)
Table 8. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Region (2022-2027) & (Kiloton)
Table 10. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Manufacturers (2016-2021) (Kiloton)
Table 14. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturers by Revenue (US$ Million) in 2020
Table 16. Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Manufacturers (2016-2021)
Table 18. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Latisse (Bimatoprost) ( CAS 155206-00-1) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Latisse (Bimatoprost) ( CAS 155206-00-1) as of 2020)
Table 20. Key Manufacturers Latisse (Bimatoprost) ( CAS 155206-00-1) Price (2016-2021) (US$/Ton)
Table 21. Latisse (Bimatoprost) ( CAS 155206-00-1) Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Latisse (Bimatoprost) ( CAS 155206-00-1) Product Type
Table 23. Date of International Manufacturers Enter into Latisse (Bimatoprost) ( CAS 155206-00-1) Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Type (2016-2021) (Kiloton)
Table 26. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Type (2016-2021)
Table 27. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Type (2016-2021)
Table 29. Latisse (Bimatoprost) ( CAS 155206-00-1) Average Selling Price (ASP) by Type (2016-2021) & (US$/Ton)
Table 30. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Type (2022-2027) & (Kiloton)
Table 31. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Ton)
Table 35. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Application (2016-2021) (Kiloton)
Table 36. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Application (2016-2021)
Table 37. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Application (2016-2021)
Table 39. Latisse (Bimatoprost) ( CAS 155206-00-1) Average Selling Price (ASP) by Application (2016-2021) & (US$/Ton)
Table 40. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Forecast by Application (2022-2027) & (Kiloton)
Table 41. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Ton)
Table 45. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) of Key Companies (2016-2021)
Table 46. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Company (2016-2021)
Table 47. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$ Million) by Company (2016-2021)
Table 48. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Company (2016-2021)
Table 49. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Type (2016-2021)
Table 50. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Type (2016-2021)
Table 51. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Latisse (Bimatoprost) ( CAS 155206-00-1) Price (US$/Ton) by Type (2016-2021)
Table 53. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Type (2022-2027)
Table 54. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Type (2022-2027)
Table 55. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Type (2022-2027)
Table 57. China Latisse (Bimatoprost) ( CAS 155206-00-1) Price (US$/Ton) by Type (2022-2027)
Table 58. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Application (2016-2021)
Table 59. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Application (2016-2021)
Table 60. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Latisse (Bimatoprost) ( CAS 155206-00-1) Price (US$/Ton) by Application (2016-2021)
Table 62. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton) by Application (2022-2027)
Table 63. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Application (2022-2027)
Table 64. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Application (2022-2027)
Table 66. China Latisse (Bimatoprost) ( CAS 155206-00-1) Price (US$/Ton) by Application (2022-2027)
Table 67. North America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2016-2021) & (Kiloton)
Table 68. North America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Country (2016-2021)
Table 69. North America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Region (2016-2021) & (Kiloton)
Table 72. Asia Pacific Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Region (2016-2021)
Table 75. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2016-2021) & (Kiloton)
Table 76. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Country (2016-2021)
Table 77. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country (2016-2021)
Table 79. Latin America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2016-2021) & (Kiloton)
Table 80. Latin America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Country (2016-2021) & (Kiloton)
Table 84. Middle East and Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country (2016-2021)
Table 87. Allergan plc (AbbVie Inc.) Corporation Information
Table 88. Allergan plc (AbbVie Inc.) Description and Business Overview
Table 89. Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 90. Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Product
Table 91. Allergan plc (AbbVie Inc.) Recent Development
Table 92. Sandoz(Novartis) Corporation Information
Table 93. Sandoz(Novartis) Description and Business Overview
Table 94. Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 95. Sandoz(Novartis) Product
Table 96. Sandoz(Novartis) Recent Development
Table 97. Hi-Tech Pharmacal Corporation Information
Table 98. Hi-Tech Pharmacal Description and Business Overview
Table 99. Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 100. Hi-Tech Pharmacal Product
Table 101. Hi-Tech Pharmacal Recent Development
Table 102. Apotex Inc. Corporation Information
Table 103. Apotex Inc. Description and Business Overview
Table 104. Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 105. Apotex Inc. Product
Table 106. Apotex Inc. Recent Development
Table 107. Latisse (Bimatoprost) ( CAS 155206-00-1) Market Trends
Table 108. Latisse (Bimatoprost) ( CAS 155206-00-1) Market Drivers
Table 109. Latisse (Bimatoprost) ( CAS 155206-00-1) Market Challenges
Table 110. Latisse (Bimatoprost) ( CAS 155206-00-1) Market Restraints
Table 111. Latisse (Bimatoprost) ( CAS 155206-00-1) Customers List
Table 112. Latisse (Bimatoprost) ( CAS 155206-00-1) Distributors List
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of FiguresFigure 1. Latisse (Bimatoprost) ( CAS 155206-00-1) Product Picture
Figure 2. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type in 2020 & 2027
Figure 3. Medicine Grade Product Picture
Figure 4. Cosmetic Grade Product Picture
Figure 5. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application in 2020 & 2027
Figure 6. Medicine
Figure 7. Cosmetic
Figure 8. Others
Figure 9. Latisse (Bimatoprost) ( CAS 155206-00-1) Report Years Considered
Figure 10. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size 2016-2027 (US$ Million)
Figure 12. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales 2016-2027 (Kiloton)
Figure 13. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Region (2016-2021)
Figure 15. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Region in 2020
Figure 16. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Region (2016-2021)
Figure 17. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Region in 2020
Figure 18. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue in 2020
Figure 20. Latisse (Bimatoprost) ( CAS 155206-00-1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type (2016-2021)
Figure 22. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Type in 2020
Figure 23. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Type (2016-2021)
Figure 24. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Type in 2020
Figure 25. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application (2016-2021)
Figure 26. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Application in 2020
Figure 27. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Application (2016-2021)
Figure 28. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Application in 2020
Figure 29. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate 2016-2027 (Kiloton)
Figure 30. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Latisse (Bimatoprost) ( CAS 155206-00-1) Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Latisse (Bimatoprost) ( CAS 155206-00-1) Players Market Share by Revenue in Latisse (Bimatoprost) ( CAS 155206-00-1) in 2020
Figure 33. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Type (2016-2021)
Figure 34. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Application (2016-2021)
Figure 36. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate 2016-2021 (Kiloton)
Figure 38. North America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Country in 2020
Figure 40. North America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country in 2020
Figure 41. U.S. Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 42. U.S. Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 44. Canada Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate 2016-2021 (Kiloton)
Figure 46. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Country in 2020
Figure 48. Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Country in 2020
Figure 49. Germany Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 50. Germany Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 52. France Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 54. U.K. Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 56. Italy Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 58. Russia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate 2016-2021 (Kiloton)
Figure 60. Asia Pacific Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share by Region in 2020
Figure 62. Asia Pacific Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share by Region in 2020
Figure 63. China Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 64. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 66. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 68. South Korea Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 70. India Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 72. Australia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 74. Taiwan Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 76. Indonesia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 78. Thailand Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (2016-2021) (Kiloton)
Figure 80. Malaysia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Growth Rate (201